| dc.contributor.author |
Marathe, Sandhya |
|
| dc.date.accessioned |
2021-09-27T07:59:54Z |
|
| dc.date.available |
2021-09-27T07:59:54Z |
|
| dc.date.issued |
2011-09-27 |
|
| dc.identifier.uri |
https://www.tandfonline.com/doi/abs/10.1517%2F14712598.2011.623124 |
|
| dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/2221 |
|
| dc.description.abstract |
Curcumin has been a front-line topic of mainstream scientific research for a variety of diseases from cancer to Alzheimer's to infectious diseases. Curcumin suppresses the type 1 immune response, which might lead to alleviation of type 1 immune response disorders. However, the inhibition of type 1 immune response might invite infections with opportunistic pathogens. Considering its low bioavailability, several curcumin derivatives have been designed to improve its functionality. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
Taylor & Francis |
en_US |
| dc.subject |
Biology |
en_US |
| dc.subject |
Bacterial and parasitic infections |
en_US |
| dc.subject |
Cancer and other metabolic |
en_US |
| dc.subject |
Curcumin |
en_US |
| dc.title |
Multifaceted roles of curcumin: two sides of a coin! |
en_US |
| dc.type |
Article |
en_US |